Tumour-specific methylation patterns detected for the S100A4, S100A6 and S100A10 genes were next assessed against basic clinical and pathological information available for all tumours (age, sex, histopathological subtype), to make a preliminary assessment of any clinicopathological significance in disease development. The gene discussed is S100A6; the disease is neoplasm.